Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousIslets of Langerhans TransplantationTransplantation ConditioningHematopoietic Stem Cell MobilizationStem Cell TransplantationGraft vs Host DiseaseHematologic NeoplasmsLeukapheresisGranulocyte Colony-Stimulating FactorGraft SurvivalBone Marrow TransplantationMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyIslets of LangerhansTreatment OutcomeCyclophosphamideBusulfanHematopoietic Stem CellsTissue DonorsMyeloablative AgonistsMultiple MyelomaCord Blood Stem Cell TransplantationTransplantation ChimeraStem CellsAntineoplastic Combined Chemotherapy ProtocolsTransplantation, IsogeneicRecurrenceLiver TransplantationImmunosuppressive AgentsRemission InductionLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingEtoposideHistocompatibilityWhole-Body IrradiationHistocompatibility TestingThiotepaPOEMS SyndromeRetrospective StudiesDisease-Free SurvivalInfectionKidney TransplantationVidarabineTime FactorsHematopoiesisLeukemiaAmyloidosisSurvival RateSalvage TherapySurvival AnalysisIfosfamideImmunosuppressionGraft vs Leukemia EffectVincristineCarmustineBlood CellsCytarabineHodgkin DiseaseLeukemia, Myeloid, AcutePlatelet CountCytomegalovirus InfectionsAnemia, AplasticMyelodysplastic SyndromesFollow-Up StudiesDiabetes Mellitus, Type 1Graft RejectionBlood Cell CountLymphomaMesenchymal Stem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionPancreas TransplantationFatal OutcomeCytophagocytosisCyclosporineNeoplasmsTransplantation ImmunologyHeart TransplantationCell TransplantationFeasibility StudiesHLA AntigensHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellPrecursor Cell Lymphoblastic Leukemia-LymphomaLivedo ReticularisBone MarrowDoxorubicinBlood DonorsLung TransplantationImmunophenotypingProspective StudiesRecombinant ProteinsBone Marrow PurgingPrednisone